文献速递血栓与止血

人类花生四烯酸12S-脂氧合酶与内源性及外源性抑制剂结合的冷冻电镜结构

Cryo-EM structures of human arachidonate 12S-lipoxygenase bound to endogenous and exogenous inhibitors.
PubMed 文献 · Blood · 2023-01-01

研究利用单颗粒冷冻电镜解析了人12-脂氧合酶(12-LOX)的高分辨率结构(1.7-2.8 Å),发现其以单体至六聚体等多种寡聚状态存在,二聚体内存在不同构象,四聚体活性位点被内源性长链酰基辅酶A占据,六聚体可同时结合花生四烯酸和选择性抑制剂ML355。

要点

  • 12-LOX可形成单体至六聚体多种寡聚状态,可能影响催化活性与膜结合。
  • 12-LOX二聚体内存在不同构象,可能代表催化周期不同时间点。
  • 四聚体活性位点被内源性长链酰基辅酶A占据,六聚体可同时结合花生四烯酸和ML355。

核心结论

  • 研究揭示了12-LOX寡聚体组装、催化机制和小分子结合的新见解,为靶向该酶的药物开发铺路。

研究设计与样本

  • 采用单颗粒冷冻电镜解析人12-LOX的高分辨率结构,分辨率范围为1.7-2.8 Å。

主要发现

  • 12-LOX可存在从单体到六聚体的多种寡聚状态,可能影响其催化活性和膜结合。
  • 在12-LOX二聚体内鉴定出不同构象,可能代表催化周期的不同时间点。
  • 12-LOX四聚体的活性位点被内源性12-LOX抑制剂长链酰基辅酶A占据。
  • 12-LOX六聚体可同时结合花生四烯酸和选择性12-LOX抑制剂ML355。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Human 12-lipoxygenase (12-LOX) is a key enzyme involved in platelet activation, and the regulation of its activity has been targeted for the treatment of heparin-induced thrombocytopenia. Despite the clinical importance of 12-LOX, the exact mechanisms by which it affects platelet activation are not fully understood, and the lack of structural information has limited drug discovery efforts. In this study, we used single-particle cryo-electron microscopy to determine high-resolution structures (1.7-2.8 Å) of human 12-LOX. Our results showed that 12-LOX can exist in multiple oligomeric states, from monomer to hexamer, which may affect its catalytic activity and membrane association. We also identified different conformations within the 12-LOX dimer, which likely represent different time points in its catalytic cycle. Furthermore, we identified small molecules bound to 12-LOX. The active site of the 12-LOX tetramer was occupied by an endogenous 12-LOX inhibitor, a long-chain acyl coenzyme A. In addition, we found that the 12-LOX hexamer can simultaneously bind to arachidonic acid and ML355, a selective 12-LOX inhibitor that has passed a phase 1 clinical trial for the treatment of heparin-induced thrombocytopenia and received a fast-track designation by the Food and Drug Administration. Overall, our findings provide novel insights into the assembly of 12-LOX oligomers, their catalytic mechanism, and small molecule binding, paving the way for further drug development targeting the 12-LOX enzyme.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Mobbs JI, Black KA, Tran M, et al. Cryo-EM structures of human arachidonate 12S-lipoxygenase bound to endogenous and exogenous inhibitors. Blood. 2023. PMID: 37506345. doi:10.1182/blood.2023020441

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。